Global Top 10 Medtechs Swap Places After Latest Quarterlies

Market pressures, changing COVID-related demand, restructuring and currency movements evident in the top medtechs’ latest financials

Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.

Shutterstock

Medtech Top 10 listings showing moving annual totals (MAT) and the most recent quarterly revenues reflect a number of changes compared to the 2021 Medtech 100 by Medtech Insight.

On an annualized basis for 2022, Abbott Laboratories Ltd posted half-a-billion dollars more in revenues than Medtronic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight